DM
PROF

Deerfield Management’s Profound Medical PROF Stock Holding History

Deerfield Management’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-732,543
Closed -$2.96M – 118
2022
Q3 		$2.96M Sell
732,543
-981,254
-57% -$6.62M 0.06% 103
2022
Q2 		$12.5M Hold
1,713,797
– – 0.26% 72
2022
Q1 		$15.4M Hold
1,713,797
– – 0.34% 58
2021
Q4 		$19.2M Buy
1,713,797
+416,000
+32% +$5.2M 0.4% 58
2021
Q3 		$19M Hold
1,297,797
– – 0.37% 71
2021
Q2 		$21.2M Hold
1,297,797
– – 0.38% 82
2021
Q1 		$26.1M Buy
1,297,797
+602,797
+87% +$14.5M 0.55% 63
2020
Q4 		$14.3M Hold
695,000
– – 0.28% 90
2020
Q3 		$12.3M Buy
+695,000
New +$11M 0.3% 78

Other funds holding PROF

GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $349M AUM 28.06% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $1.1B AUM 171.86% 1-Year Est. Return

Deerfield Management's PROF Position: Q4 2022 in Review

Deerfield Management sold out of Profound Medical (PROF) in Q4 2022, closing a stake of 732,543 shares — an estimated $2.96M sold.

Deerfield Management first reported a position in PROF in Q3 2020 and held it in 9 quarters. The position peaked at $26.1M in Q1 2021. 34 funds tracked by Wall St. Rank hold PROF as of Q4 2022.

  • Deerfield Management reported no remaining Profound Medical position as of Q4 2022 after selling out during the quarter.
  • Deerfield Management sold 732,543 Profound Medical shares in Q4 2022, an estimated $2.96M.
  • Deerfield Management first reported a position in Profound Medical in Q3 2020 and held it in 9 quarters.
  • Deerfield Management's Profound Medical position peaked at $26.1M in Q1 2021.
  • 34 funds tracked by Wall St. Rank held Profound Medical as of Q4 2022.

Based on Deerfield Management's 13F filing for Q4 2022, filed 14 Feb 2023.